U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global research initiative involving hundreds of scientists to determine the source of rising autism rates, which reached 1 in 36 children by 2020, according to the CDC.
“We’ll know by September what has caused the autism epidemic and how to eliminate those exposures,” Kennedy said, hinting at environmental and artificial factors. The initiative is part of Trump’s broader “Make America Healthy Again” Commission, which is also reviewing rising childhood conditions like asthma and ADHD.
The autism community, however, responded with skepticism. Kristyn Roth of the Autism Society of America criticized the deadline and the framing of autism as an “epidemic,” warning it promotes fear and stigmatization. Experts caution that increased diagnoses are largely due to expanded diagnostic criteria and awareness, not an unknown epidemic.
Kennedy, known for promoting a disproven link between vaccines and autism, confirmed vaccines will be reviewed, along with potential environmental and lifestyle triggers. Meanwhile, a recent study has strengthened ties between prenatal diabetes and autism risk.
Controversy deepened after reports surfaced of David Geier—previously fined for unlicensed medical practices—being hired to investigate vaccine links. Lawmakers and advocacy groups fear the spread of misinformation under Kennedy’s leadership.
The National Institutes of Health and the CDC, both under Kennedy’s purview, are planning multimillion-dollar research efforts into autism causes, including vaccine-related studies. Critics argue the push may politicize science and mislead the public.
Despite widespread concern, Kennedy remains firm: “There will be no bigger news than finding the cause of autism.” Whether science can meet his deadline remains uncertain.


Senate Majority Leader John Thune Moves to Advance Crypto Clarity Act
Trump Administration Releases New UFO Files and Apollo Mission Records
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
New Zealand MMP Electoral System Faces Fresh Referendum Debate
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
US ‘Digging In’ Across Indo-Pacific, Pentagon Official Says
SEC Moves to Dismiss Insider Trading Case Against Trump-Pardoned Terren Peizer
Neuralink Expands Brain Implant Trials with 12 Global Patients
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Ukraine Agrees to Protect Kazakhstan Oil Exports via Black Sea
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



